Debt-to-equity of eFFECTOR Therapeutics, Inc. from 30 Sep 2021 to 31 Mar 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: eFFECTOR Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 31 Mar 2024.
eFFECTOR Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Mar 2024 was -1590%, a 577% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

eFFECTOR Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	-1590%	-1923%	-577%	31 Mar 2024
Q4 2023	-846%	-1009%	-619%	31 Dec 2023
Q3 2023	-4348%	-4498%	-3014%	30 Sep 2023
Q2 2023	767%	+487%	+174%	30 Jun 2023
Q1 2023	333%	+474%		31 Mar 2023
Q4 2022	163%	+214%		31 Dec 2022
Q3 2022	149%	+177%		30 Sep 2022
Q2 2022	280%			30 Jun 2022
Q1 2022	-141%			31 Mar 2022
Q4 2021	-51%			31 Dec 2021
Q3 2021	-28%			30 Sep 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.